• Aspen Pharmacare disclosed that Public Investment Corp. raised its beneficial interest to 20.1% of the company’s issued ordinary shares.
• The threshold was reached through aggregate purchases of ordinary shares.
• The disclosure was dated July 2, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspen Pharmacare Holdings Ltd. published the original content used to generate this news brief via SENS, the regulatory disclosure system operated by the Johannesburg Securities Exchange (JSE) (Ref. ID: S523573), on July 02, 2026, and is solely responsible for the information contained therein.